LSL Web-Exclusive Content

  1. Unleashing Team Potential: The Power Of Emotional Intelligence In Leadership 9/27/2023

    Emotional intelligence refers to an individual’s ability to “recognize, use, understand, and manage their emotions in a positive way,” explains PsychCentral. While expressing and controlling one’s own emotions is imperative as an executive, so is the ability to understand, interpret, and respond to the emotions of others.

  2. Can DCTs Be Both Patient Centric And Financially Efficient For Sites? 9/22/2023

    While DCTs have the potential to provide more convenience and improved access for patients, the anticipated cost savings touted for these trials have yet to materialize fully at the site level. In fact, the opposite has occurred in some instances.

  3. Moderna Addresses Awareness Gap, Builds Community Trust To Boost CMV Trial Recruitment 9/20/2023

    Fewer than one in four Americans are aware of the leading cause of pediatric birth defects — a common and contagious viral infection known as cytomegalovirus, (CMV). Moderna aims to overcome this awareness gap and enroll patients in CMV trials using lessons learned from its COVID-19 clinical trials.

  4. The Risks Of Trying To Emulate The 800-Pound Gorillas Of Business 9/19/2023

    It's important to remember that what works for behemoth companies may not necessarily align with the reality of smaller enterprises — especially when it comes to hiring.

  5. Essential Elements Of Technology Transfer 9/19/2023

    The principles of an effective technology transfer can apply at every stage of the drug development lifecycle for biotech companies of every size. Tech transfer programs are usually bespoke, but they share common essential elements. This article breaks them down.

  6. Navigating The Hype Of AI In Clinical Research 9/18/2023

    When you consider the rising cost of healthcare in America, a shortage amounting to tens of thousands of physicians, and economic headwinds stirring fear across the field, we can’t afford to not use AI. We shouldn’t be asking ourselves questions of why, but rather, why not. But that begs a new question: Why haven’t we seen the impact, adoption, and value of AI more broadly across clinical research?

  7. Moving From Clinical Stage To Commercial? 4 Steps For An Outsourcing Strategy 9/18/2023

    If you're a pre-commercial bio/pharma looking ahead to commercial stage, evaluating partnerships are faced with making key decisions around which capabilities to outsource, the degree of data access and ownership, and which external partners are the right fit. Here are four key actions to consider.

  8. Survey Results Show What Could Finally Make Sustainability Stick 9/8/2023

    Results from BioPlan's "20th Annual Report of Biopharmaceutical Manufacturing and Production" show that lasting sustainability strategies should focus on profitability aspects. That's because, even more than a spirit of stewardship, financial advantages provide a powerful incentive to stick to the plan.

  9. Cautious Optimism For Biotechs And Their Outsourcing Partners 9/5/2023

    Pre-revenue, including preclinical and clinical stage, biotechs have been the most impacted but also stand to gain the most after the economic downturn and subsequent recovery. This article will delve into how small to midsize pre-revenue biotechs have been specifically impacted and what this could mean for organizations that support them.

  10. 5 Best Practices For Responding To FDA Form 483 Inspection Observations 9/1/2023

    How you respond to FDA Form 483 observations will determine if they escalate into more serious consequences, such as a warning letter or enforcement action. You don't want that. Follow this 5-step action plan to make sure the findings are properly addressed.